Showing results (91-100 of 270) with videos related to

Sort By:
Pageof 27
Journal of Cardiovascular Pharmacology|January 1, 1988
Factors determining the response to calcium antagonists in hypertensionR Donnelly, J L Reid, P A Meredith, et al.
British Journal of Clinical Pharmacology|May 1, 1987
Adimolol, a long acting beta-adrenoceptor blocker in manH L Elliott, C R Jones, N M Deighton, et al.
British Journal of Clinical Pharmacology|July 1, 1983
The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjectsP A Meredith, H L Elliott, D R McSharry, et al.
British Journal of Clinical Pharmacology|June 1, 1991
The effect of renal impairment on the pharmacokinetics and metabolism of bopindololN J MacDonald, A C Grant, R S Rodger, et al.
International Journal of Clinical Pharmacology Research|January 1, 1984
Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensivesH L Elliott, P A Meredith, C W Howden, et al.
British Journal of Clinical Pharmacology|August 1, 1985
Verapamil pharmacokinetics and apparent hepatic and renal blood flowP A Meredith, H L Elliott, F Pasanisi, et al.
Journal of Hypertension|December 1, 1995
Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40-5967), a novel calcium antagonistJ R Petrie, S K Glen, M MacMahon, et al.
British Journal of Clinical Pharmacology|October 1, 1991
A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteersJ D Gemmill, C A Howie, P A Meredith, et al.
Pageof 27